论文信息 - A randomised double-blind placebo controlled clinical trial assessing the tolerability and efficacy of glutathione as an adjuvant to escalating doses of cisplatin in the treatment of advanced ovarian cancer. - 字舞流文

A randomised double-blind placebo controlled clinical trial assessing the tolerability and efficacy of glutathione as an adjuvant to escalating doses of cisplatin in the treatment of advanced ovarian cancer.

D. Pickering | R. Coleman | C. Topham | P. Harper | F. Parnis | J. Whittington | M. Tedeschi

[1] G. Pezzoni,et al. Reduced glutathione protects against cisplatin-induced neurotoxicity in rats. , 1993, Cancer research.

[2] F. Zunino,et al. High-dose cisplatin and cyclophosphamide with glutathione in the treatment of advanced ovarian cancer. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

[3] Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer , 1992, The Lancet.

[4] F. Zunino,et al. Peripheral Neurotoxicity following High-Dose Cisplatin with Glutathione: Clinical and Neurophysiological Assessment , 1992, Tumori.